Publication | Closed Access

P.1.091 Olanzapine's efficacy for relapse prevention in bipolar disorder: A randomized double-blind placebo-controlled 12-month clinical trial

PsychiatryAddictionP.1.091 OlanzapinePsychotropic MedicationDepressionAddiction MedicineClinical PsychiatryPsychiatric DisorderMental HealthRelapse PreventionMedicinePsychopathologyBipolar Disorder